A federal judge has ruled that a Zoloft class action lawsuit filed against the drug’s manufacturer will be heard in a St. Louis court. The lawsuit alleges that Pfizer Inc. failed to properly warn patients that women who use Zoloft during pregnancy are at an increased risk of giving birth to a child with severe birth defects.
The Zoloft class action was filed on behalf of 21 children with birth defects, all of whom were born to mothers who were prescribed the antidepressant during pregnancy. Pfizer attempted to move the case to a federal court before a judge ordered the case to continue in St. Louis.
Zoloft is an antidepressant in a class known as selective serotonin reuptake inhibitors (SSRIs). Recent studies have linked the drug to and increased risk of severe birth defects, including septal defects and persistent pulmonary hypertension of the newborn (PPHN).